179 related articles for article (PubMed ID: 25454821)
21. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.
Weiss D; Stockmann C; Schrödter K; Rudack C
Cell Oncol (Dordr); 2013 Jun; 36(3):213-24. PubMed ID: 23529585
[TBL] [Abstract][Full Text] [Related]
22. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
[TBL] [Abstract][Full Text] [Related]
23. DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients.
Laytragoon-Lewin N; Chen F; Castro J; Elmberger G; Rutqvist LE; Lewin F; Turesson I; Lundgren J
Anticancer Res; 2010 Nov; 30(11):4643-8. PubMed ID: 21115918
[TBL] [Abstract][Full Text] [Related]
24. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
25. LHX6 is a sensitive methylation marker in head and neck carcinomas.
Estécio MR; Youssef EM; Rahal P; Fukuyama EE; Góis-Filho JF; Maniglia JV; Goloni-Bertollo EM; Issa JP; Tajara EH
Oncogene; 2006 Aug; 25(36):5018-26. PubMed ID: 16732332
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.
Zhang XY; Li M; Sun K; Chen XJ; Meng J; Wu L; Zhang P; Tong X; Jiang WW
Oncotarget; 2015 Jan; 6(1):101-15. PubMed ID: 25575809
[TBL] [Abstract][Full Text] [Related]
28. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
Poetsch M; Lorenz G; Kleist B
Cancer Genet Cytogenet; 2002 Jan; 132(1):20-4. PubMed ID: 11801303
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic and genetic alterations affect the WWOX gene in head and neck squamous cell carcinoma.
Ekizoglu S; Bulut P; Karaman E; Kilic E; Buyru N
PLoS One; 2015; 10(1):e0115353. PubMed ID: 25612104
[TBL] [Abstract][Full Text] [Related]
30. Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted.
Poage GM; Christensen BC; Houseman EA; McClean MD; Wiencke JK; Posner MR; Clark JR; Nelson HH; Marsit CJ; Kelsey KT
PLoS One; 2010 Mar; 5(3):e9651. PubMed ID: 20300172
[TBL] [Abstract][Full Text] [Related]
31. Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation.
Mochizuki D; Misawa Y; Kawasaki H; Imai A; Endo S; Mima M; Yamada S; Nakagawa T; Kanazawa T; Misawa K
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469511
[TBL] [Abstract][Full Text] [Related]
32. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage.
Smith IM; Mydlarz WK; Mithani SK; Califano JA
Int J Cancer; 2007 Oct; 121(8):1724-8. PubMed ID: 17582607
[TBL] [Abstract][Full Text] [Related]
33. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
[TBL] [Abstract][Full Text] [Related]
34. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.
Bennett KL; Karpenko M; Lin MT; Claus R; Arab K; Dyckhoff G; Plinkert P; Herpel E; Smiraglia D; Plass C
Cancer Res; 2008 Jun; 68(12):4494-9. PubMed ID: 18559491
[TBL] [Abstract][Full Text] [Related]
35. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
[TBL] [Abstract][Full Text] [Related]
36. Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas.
Bernaldo de Quirós S; Merlo A; Secades P; Zambrano I; de Santa María IS; Ugidos N; Jantus-Lewintre E; Sirera R; Suarez C; Chiara MD
BMC Cancer; 2013 Mar; 13():116. PubMed ID: 23497198
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
38. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract][Full Text] [Related]
39. Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer.
Worsham MJ; Chen KM; Stephen JK; Havard S; Benninger MS
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):116-21, 121.e1-19. PubMed ID: 20620629
[TBL] [Abstract][Full Text] [Related]
40. MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.
Pattani KM; Soudry E; Glazer CA; Ochs MF; Wang H; Schussel J; Sun W; Hennessey P; Mydlarz W; Loyo M; Demokan S; Smith IM; Califano JA
PLoS One; 2012; 7(9):e45534. PubMed ID: 23029077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
